Private equity fundraising struggled in 2024, with total capital raised declining for the third consecutive year. Read more ...

Private-equity executives entered 2025 with high hopes for a dealmaking recovery that is lifting payouts to fund investors ...

Wall Street is still awaiting regulatory approval for the first full-blown private-asset ETFs, but for now opportunistic ...

Bluebird Bio will sell itself to private equity firms Carlyle and SK Capital for about $30 million, the company said Friday.

With private asset ETFs still awaiting regulatory approval, opportunistic issuers are continuing to crank out products that ...

The Tasmania JackJumpers are officially off the market after a deal was struck by owner Larry Kestelman to sell the reigning ...

Focus Healthcare Partners, which focuses on senior living assets, has purchased a bankrupt New York property for $86 million.

Health Affairs' Jeff Byers welcomes Senior Editor Kathleen Haddad back to the program to discuss two recent reports exploring the impacts of private equity on the US health care system.

TORONTO — Onex Corp. reported a loss in its fourth quarter compared with a profit a year earlier. The private equity firm, ...

Wojcicki and New Mountain have offered to acquire all of 23andMe's outstanding shares in cash for $2.53 per share, or an ...

Baby Boomers are "the luckiest generation" in America and the most entitled in recent history, how did they get so lucky?

Markets worldwide defied expectations in 2024 led by the dominating performance of mega-cap technology stocks known as the ...